News
RIBOPRO Secures Series A Funding to Accelerate mRNA-Based technologies
RIBOPRO, a leading technology and service provider, specializing in the development and production of mRNA and lipid nanoparticles, today proudly announced the successful closing of a Series A funding round.
These are the Venture Challenge Fall 2024 teams!
Six teams have started the Venture Challenge Fall 2024! Between These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.
iProtics secures significant investment of €350,000 from UNIIQ!
We are thrilled to announce that iProtics has secured its first investment, receiving €350,000 from UNIIQ - Finance for the Future the Zuid-Holland innovation fund.
Venture Challenge alumnus Predica is proud to announce its first product, the “HPV profiler”
Predica Diagnostics B.V. is active in the field of diagnostics, prognostics and prediction of treatment response in oncology. in 2018 Predica Diagnostic participated in the Venture Challenge spring edition.
The LifeSciences@Work Venture Challenge Winner announcement at the DLSC
During the 20th edition of the foremost life sciences business networking event, the winner of the Venture Challenge Fall 2024 will be announced. Curious about the teams of this fall edition?
XS Innovations raises seed investment of EUR 1.1 m to accelerate development of vascular access device “the Dynamic AVF”
• Investment will accelerate development of a state-of-the-art vascular access device known as Dynamic AVF, to improve treatment for end-stage kidney disease patients
Spatium Medical B.V. raises 5 million to bring smart insufflation technology to operating rooms in europe and the United States
Venture Challenge alumnus of the spring edition 2023, Spatium Medical B.V., has successfully closed a €5 million funding round. This round includes new investors InnovationQuarter and DEMCON INVESTMENTS Fund, as well as support from existing investors: Van
Applications for the Termeer Fellowship Class of 2025 will open from September 30th!
Are you an early-stage CEO of an early or non-profit biotech/life sciences organisation committed to developing potentially life-changing treatments for patients?
Pitching Applications for HealthTech Investor Summit Open Now!
Pitching applications are in full swing for the HealthTech Investor Summit in December!
Een kijkje achter de schermen bij de toekenningspartijen
De Nederlandse LSH-sector blinkt uit door de intensieve samenwerking met internationale topwetenschappers en de dynamische band tussen het bedrijfsleven en de academische wereld.